Document is current
Any future updates will be listed below
-
Authors
Kianersi, Sina https://orcid.org/0000-0003-0950-2675
Potts, Kaitlin S.
Wang, Heming
Sofer, Tamar
Noordam, Raymond https://orcid.org/0000-0001-7801-809X
Rutter, Martin K.
Redline, Susan https://orcid.org/0000-0002-6585-1610
Huang, Tianyi https://orcid.org/0000-0001-8420-9167
- License Information
-
More Information
Article History
Received: 5 December 2024
Revised: 5 December 2024
Accepted: 24 March 2025
First Online: 6 April 2025
Competing interests
: MKR reports receiving consultancy fees from Eli Lilly and has modest stock ownership in GSK, unrelated to this work. The other authors have no conflicts of interest to declare.
: All methods were performed in accordance with the relevant guidelines and regulations. National Health Service North-West Multi-Centre Research Ethics Committee approved the UK Biobank study, and all participants provided written informed consent at baseline.
